Revolving door redux: The DEA's recently departed No. 2 returns to a Big Pharma consulting firm

Washington's revolving door kept spinning this week as the DEA's recently departed second-in-command returned for a new stint with the high-powered consulting firm where he previously advised Purdue Pharma and a drug distributor.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...